Perdoceo Education
PRDO
32.19
+0.13
+0.41%
Perdoceo Education
US · PRDO
#2783 by market cap
Listed 1970
32.19
+0.13
+0.41%
Live - 5344 symbols - heartbeat 454s ago
· 2026-10-08 04:01
Pre-market
31.83
-1.13%
After-hours
32.19
0.00%
- Market cap
- 2.01B
- P/E (TTM)i
- 11.71
- P/Bi
- 1.95
- EPSi
- 2.42
- Div yieldi
- 1.86%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on PRDO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.01, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +24.20% YoY
Margins
- Gross margin
- 76.65%
- Operating margin
- 26.65%
- Net margin
- 18.90%
Key ratios & quality
- PEG ratioi
- 0.63
- Altman Z-Scorei
- 7.01
PEG uses trailing P/E against the 3-year net income growth rate (18.60%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 581.30M | 627.70M | 687.31M | 693.03M | 695.21M | 710.00M | 681.26M | 846.10M |
| Gross profit | 471.40M | 525.76M | 575.55M | 584.29M | 578.49M | 579.68M | 560.40M | 648.56M |
| Selling & admin expenses | 358.67M | 386.68M | 369.65M | 374.16M | 384.55M | 364.87M | 333.33M | 381.43M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 103.34M | 129.93M | 191.11M | 193.37M | 174.21M | 197.92M | 212.43M | 225.50M |
| Pretax profit | 74.35M | 93.02M | 146.83M | 149.07M | 134.27M | 192.12M | 201.44M | 216.84M |
| Tax | 18.56M | 22.43M | 22.48M | 39.43M | 38.40M | 44.47M | 53.85M | 56.92M |
| Net profit | 55.18M | 69.98M | 124.26M | 109.64M | 95.87M | 147.65M | 147.59M | 159.91M |
| Basic EPS | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 |
| Diluted EPS | 0.77 | 0.97 | 1.74 | 1.55 | 1.39 | 2.18 | 2.19 | 2.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 213.00M | 209.58M | 211.87M | 211.64M | 221.74M | 213.36M |
| Gross profit | 164.46M | 159.34M | 162.73M | 162.02M | 174.68M | 162.46M |
| Selling & admin expenses | 93.37M | 92.34M | 93.84M | 101.88M | 96.46M | 93.41M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 59.29M | 56.86M | 58.87M | 50.49M | 68.87M | 59.71M |
| Pretax profit | 56.51M | 56.24M | 56.02M | 48.07M | 68.13M | 60.21M |
| Tax | 12.82M | 15.21M | 16.17M | 12.72M | 14.18M | 12.24M |
| Net profit | 43.69M | 41.03M | 39.85M | 35.35M | 53.95M | 47.97M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.65 | 0.62 | 0.60 | 0.54 | 0.85 | 0.75 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 269.45M | 360.39M | 467.06M | 554.45M | 575.12M | 654.96M | 640.15M | 696.86M |
| Cash & ST investments | 228.82M | 294.18M | 406.36M | 494.20M | 508.72M | 603.14M | 568.93M | 622.18M |
| Inventory | 763.00K | 576.00K | 596.00K | 904.00K | 1.90M | 5.00M | 3.39M | 4.05M |
| Total assets | 482.49M | 599.15M | 721.52M | 847.43M | 957.37M | 1.01B | 1.24B | 1.25B |
| Total current liabilities | 97.05M | 103.81M | 103.82M | 140.24M | 163.38M | 111.04M | 132.16M | 137.81M |
| Short-term debt | -- | 11.78M | 9.79M | 9.40M | 6.56M | 5.70M | 13.26M | 11.49M |
| Long-term debt | -- | -- | -- | -- | -- | -- | 56.50M | -- |
| Total liabilities | 127,290,000.00 | 167,851,000.00 | 165,610,000.00 | 197,323,000.00 | 231,523,000.00 | 165,895,000.00 | 277,498,000.00 | 275,305,000.00 |
| Total equity | 355.20M | 431.30M | 555.91M | 650.11M | 725.85M | 841.42M | 959.54M | 972.41M |
| Retained earnings | -52.95M | 18.07M | 142.34M | 251.97M | 347.84M | 480.61M | 595.67M | 718.37M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 686.00M | 721.21M | 736.15M | 696.86M | 747.35M | 802.63M |
| Cash & ST investments | 590.58M | 637.99M | 647.31M | 622.18M | 679.15M | 734.00M |
| Inventory | 3.25M | 2.64M | 4.02M | 4.05M | 3.28M | 2.59M |
| Total assets | 1.27B | 1.29B | 1.30B | 1.25B | 1.29B | 1.33B |
| Total current liabilities | 153.96M | 168.80M | 164.64M | 137.81M | 155.18M | 171.07M |
| Short-term debt | 10.37M | 10.66M | 11.08M | 11.49M | 14.01M | 14.23M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 298,289,000.00 | 309,756,000.00 | 301,533,000.00 | 275,305,000.00 | 288,864,000.00 | 301,082,000.00 |
| Total equity | 970.26M | 984.63M | 997.85M | 972.41M | 999.91M | 1.03B |
| Retained earnings | 630.54M | 662.86M | 692.76M | 718.37M | 762.68M | 801.04M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 56.99M | 73.09M | 179.96M | 191.12M | 148.19M | 112.03M | 161.59M | 225.24M |
| Depreciation & amortization | 9.39M | 9.15M | 14.79M | 16.77M | 19.73M | 16.89M | 14.65M | 41.63M |
| Free cash flow | 50.26M | 67.91M | 170.19M | 180.66M | 135.57M | 105.61M | 156.97M | 216.66M |
| Dividends paid | -- | -- | -- | 0 | 0 | -14.42M | -31.70M | -36.86M |
| Stock buybacks / issuance | 1.68M | -2.10M | -12.14M | -24.44M | -21.92M | -5.76M | -4.54M | -119.15M |
| Ending cash balance | 32.73M | 108.69M | 109.68M | 325.18M | 118.88M | 119.02M | 131.75M | 132.28M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 65.13M | 78.78M | 41.23M | 40.11M | 69.39M | 74.63M |
| Depreciation & amortization | 11.81M | 10.15M | 10.02M | 9.66M | 9.35M | 9.34M |
| Free cash flow | 63.39M | 76.03M | 39.37M | 37.88M | 67.65M | 73.08M |
| Dividends paid | -9.20M | -8.52M | -9.67M | -9.47M | -10.28M | -9.42M |
| Stock buybacks / issuance | -24.21M | -20.57M | -20.35M | -54.01M | -7.64M | -6.59M |
| Ending cash balance | 153.65M | 193.68M | 180.78M | 132.28M | 165.12M | 163.71M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.94 | 17.80 | 25.18 | 18.18 | 13.93 | 18.84 | 16.39 | 16.55 |
| ROA %i | 11.87 | 12.94 | 18.82 | 13.98 | 10.62 | 15.03 | 13.15 | 12.87 |
| ROIC %i | 16.28 | 14.27 | 21.93 | 16.81 | 12.55 | 16.29 | 12.94 | 13.32 |
| 5-year avg ROE %i | -6.13 | 7.10 | 8.78 | 13.55 | 18.41 | 18.79 | 18.50 | 16.78 |
| EBIT margin %i | 12.91 | 14.85 | 21.39 | 21.64 | 19.37 | 27.12 | 29.66 | 26.39 |
| FCF / sales %i | 8.65 | 10.82 | 24.76 | 26.07 | 19.50 | 14.88 | 23.04 | 25.61 |
| Current ratioi | 2.78 | 3.47 | 4.50 | 3.95 | 3.52 | 5.90 | 4.84 | 5.06 |
| Quick ratioi | 2.68 | 3.38 | 4.37 | 3.84 | 3.40 | 5.74 | 4.52 | 4.75 |
| Debt / assetsi | 0.00 | 10.71 | 7.37 | 5.30 | 3.53 | 2.69 | 10.63 | 9.48 |
| LT debt / equityi | -- | 12.15 | 7.81 | 5.47 | 3.76 | 2.54 | 12.33 | 10.99 |
| Interest coveragei | 110.18 | 558.02 | 880.22 | 163.05 | 336.67 | 476.55 | 329.61 | 34.54 |
| Revenue CAGR (3Y) %i | -11.80 | -3.77 | 4.84 | 6.04 | 3.46 | 1.09 | -0.57 | 6.77 |
| Net income CAGR (3Y) %i | 2.07 | -- | -- | 25.72 | 11.06 | 5.92 | 10.42 | 18.60 |
| FCF CAGR (3Y) %i | -- | 207.05 | -- | 53.19 | 25.91 | -14.70 | -4.58 | 16.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.54 | 16.39 | 16.14 | 16.55 | 17.28 | 17.55 |
| ROA %i | 13.09 | 13.02 | 12.92 | 12.87 | 13.31 | 13.48 |
| ROIC %i | 13.29 | 13.41 | 13.47 | 13.32 | 14.02 | 14.32 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 28.52 | 27.54 | 26.75 | 26.39 | 27.46 | 27.79 |
| FCF / sales %i | 23.01 | 26.71 | 24.02 | 25.61 | 25.84 | 25.39 |
| Current ratioi | 4.46 | 4.27 | 4.47 | 5.06 | 4.82 | 4.69 |
| Quick ratioi | 4.20 | 4.03 | 4.22 | 4.75 | 4.68 | 4.56 |
| Debt / assetsi | 10.06 | 9.62 | 9.35 | 9.48 | 9.10 | 8.53 |
| LT debt / equityi | 12.09 | 11.57 | 11.06 | 10.99 | 10.32 | 9.63 |
| Interest coveragei | 105.64 | 61.22 | 43.66 | 34.54 | 37.21 | 38.55 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Colorado Technical University (CTU) is the largest reported line at 54.15% of revenue, across 4 reported segments.
- The American InterContinental University System (AIUS) follows at 26.80%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Colorado Technical University (CTU)54.15%
The American InterContinental University System (AIUS)26.80%
University of St. Augustine for Health Sciences (USAHS)18.96%
Quote time 2026-10-08 04:01:20 · For reference only, not investment advice and not tailored to your situation.